JeanneEO'BrienMDMSCI

PubMed

• Selective disruption of ER{alpha} DNA-binding activity alters uterine responsiveness to estradiol.
  Hewitt, S.C., O'Brien, J.E., Jameson, J.L., Kissling, G.E., Korach, K.S.> ;Mol Endocrinol. 2009-12-01
• Estrogen-induced proliferation of uterine epithelial cells is independent of estrogen receptor alpha binding to classical estrogen response elements.
  O'Brien, J.E., Peterson, T.J., Tong, M.H., Lee, E., Pfaff, L.E., Hewitt, S.C., Korach, K.S., Weiss, J., Jameson, J.L.> ;J Biol Chem. 2006 Sep 8
• 64 citations
  Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions
  Jeanne E. O'Brien, Eric D. Peterson, Gordon Keeler, Lisa G. Berdan, E. Magnus Ohman, David P. Faxon, Alice K. Jacobs, Eric J. Topol, Robert M. Califf> ;Journal of the American College of Cardiology. 1996 Nov 1
• Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity.
  Bezouska K, Yuen CT, O'Brien J, Childs RA, Chai W, Lawson AM, Drbal K, Fiserová A, Pospísil M, Feizi T> ;Nature. 1994-11-10
• Sulfated blood group Lewis(a). A superior oligosaccharide ligand for human E-selectin.
  Yuen CT, Bezouska K, O'Brien J, Stoll M, Lemoine R, Lubineau A, Kiso M, Hasegawa A, Bockovich NJ, Nicolaou KC> ;J. Biol. Chem.. 1994-01-21
• Join now to see all